Reuters logo
BRIEF-Zealand Pharma regains control of elsiglutide
June 12, 2017 / 6:59 AM / 3 months ago

BRIEF-Zealand Pharma regains control of elsiglutide

June 12 (Reuters) - ZEALAND PHARMA A/S

* ‍HELSINN RETURNS ELSIGLUTIDE TO ZEALAND​

* ZEALAND NOW HAS FULL RIGHTS TO DEVELOP PRODUCTS WITHIN CANCER-SUPPORTIVE CARE

* ‍HELSINN RETURNS ELSIGLUTIDE FOR TREATMENT OF CHEMOTHERAPY-INDUCED DIARRHEA TO ZEALAND CONCLUDING LICENCE AGREEMENT BETWEEN COS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below